Research ExplorerJournalsCNS DRUGS

CNS DRUGS

Bibliographical data

ISSNs1172-7047
Electronic ISSN 1172-7047

Publications

Current and Emerging Treatment Strategies for Neuronal Ceroid Lipofuscinoses
Kohlschütter, A., Schulz, A., Bartsch, U. & Storch, S., 04.2019, In: CNS DRUGS. 33, 4, p. 315-325 11 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
Westphal, M., Maire, C. L. & Lamszus, K., 09.2017, In: CNS DRUGS. 31, 9, p. 723-735 13 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management
Lüdecke, D., Schöttle, D., Karow, A., Lambert, M. & Naber, D., 01.01.2015, In: CNS DRUGS. 29, 1, p. 41-6 6 p.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians.
Naber, D. & Lambert, M., 2009, In: CNS DRUGS. 23, 8, p. 649-659 8.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life.
Lambert, M. & Naber, D., 2004, In: CNS DRUGS. 18, 2, p. 3-5 2.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (5)